Teplitsky Liane Rae's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Sep 2, 2026
- Accession no.
- 0001437749-26-029545
- Filed
- Sep 2, 2026, 7:38 PM ET
- Trade date
- Aug 31-Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $100.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Teplitsky Liane RaeCIK 0002132552 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | PPurchaseAcquired | +1,024 | $48.80 | +$49,971.2 | 3,094 | Direct | |
| Sep 1, 2026 | Common Stock | PPurchaseAcquired | +1,001 | $49.95 | +$49,999.95 | 4,095 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.